Betydelsen av MRD negativitet vid MM
Length: 00:44:20
onsdag september 8, 2021, – hrs
Watch the webinar againWatch the webinar again
Scientific program
Speakers
MD, PhD Ola Landgren
Leader of Experimental Therapeutics Program & Leader of Myeloma Service,
Landgren Lab,
Medicine,
US
MAT-SE-2100896 (v1.0) sept 2021
